Pancreatic stone protein as a novel marker for neonatal sepsis (Q45063463)

9 December 2017

title

Pancreatic stone protein as a novel marker for neonatal sepsis (English)

1 reference

9 December 2017

1

1 reference

9 December 2017

2

1 reference

9 December 2017

7

1 reference

9 December 2017

8

1 reference

9 December 2017

Andreas Woerner

3

1 reference

9 December 2017

Matteo Fontana

4

1 reference

9 December 2017

Urs Zimmermann-Baer

5

1 reference

9 December 2017

David Glauser

6

1 reference

9 December 2017

Christoph Müller

9

1 reference

9 December 2017

Mathias Nelle

10

1 reference

9 December 2017

Martin Stocker

11

1 reference

9 December 2017

publication date

8 January 2013

1 reference

9 December 2017

published in

Intensive Care Medicine

1 reference

9 December 2017

volume

39

1 reference

9 December 2017

issue

4

1 reference

9 December 2017

page(s)

754-763

1 reference

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Management of neonates with suspected or proven early-onset bacterial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Outcome and prognostic factors in neonates with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Procalcitonin as an early marker of infection in neonates and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Macrophage migration inhibitory factor: a regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention St

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Rapid quantitative procalcitonin measurement to diagnose nosocomial infections in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Use of leukocyte counts in evaluation of early-onset neonatal sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Blood culture and bacteremia predictors in infants less than three months of age with fever without source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

How Reliable Is a Negative Blood Culture Result? Volume of Blood Submitted for Culture in Routine Practice in a Children's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2798-3

Protection from septic shock by neutralization of macrophage migration inhibitory factor

21 January 2018

1 reference

12 December 2020

Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial

1 reference

12 December 2020

Combination biomarkers to diagnose sepsis in the critically ill patient

1 reference

12 December 2020

A polymorphism in the macrophage migration inhibitory factor promoter is associated with bronchopulmonary dysplasia

1 reference

12 December 2020

MIF regulates innate immune responses through modulation of Toll-like receptor 4

1 reference

12 December 2020

Procalcitonin in detecting neonatal nosocomial sepsis

1 reference

12 December 2020

Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates

1 reference

12 December 2020

Neonatal infections in China, Malaysia, Hong Kong and Thailand

1 reference

12 December 2020

10.1007/S00134-012-2798-3

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1051050008

0 references

1 reference